HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bryan Kluck Selected Research

Hemorrhage

10/2021Protease-Activated Receptor Antagonist for Reducing Cardiovascular Events - A Review on Vorapaxar.
10/2021Comparative Safety and Effectiveness of Loading Doses of P2Y12 Inhibitors in Patients Undergoing Elective PCI: a Network Meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bryan Kluck Research Topics

Disease

6Ischemic Stroke
10/2021 - 01/2012
2Hemorrhage
10/2021 - 10/2021
2Stroke (Strokes)
10/2021 - 09/2018
1Peripheral Arterial Disease
10/2021
1Acute Coronary Syndrome
10/2021
1Infarction (Infarctions)
01/2012
1Paradoxical Embolism
01/2012
1Coronary Restenosis
08/2002
1Diabetes Mellitus
08/2002

Drug/Important Bio-Agent (IBA)

2Clopidogrel (Plavix)FDA Link
10/2021 - 10/2021
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2021
1Pharmaceutical PreparationsIBA
10/2021
1vorapaxarIBA
10/2021
1Prasugrel HydrochlorideFDA Link
10/2021
1TicagrelorIBA
10/2021
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
10/2021
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2012
1Iridium-192IBA
08/2002

Therapy/Procedure

5Therapeutics
09/2018 - 01/2012
4Catheters
08/2013 - 08/2002
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2021
1Thrombolytic Therapy
01/2012
1Brachytherapy
08/2002
1Radiotherapy
08/2002
1Stents
08/2002